400 related articles for article (PubMed ID: 15886313)
1. Multimodality therapy for stage III non-small-cell lung cancer.
Farray D; Mirkovic N; Albain KS
J Clin Oncol; 2005 May; 23(14):3257-69. PubMed ID: 15886313
[TBL] [Abstract][Full Text] [Related]
2. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
3. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
Hoffmann H
Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
[TBL] [Abstract][Full Text] [Related]
4. Multimodality therapy for non-small-cell lung cancer.
Lilenbaum RC; Green MR
Oncology (Williston Park); 1994 May; 8(5):25-31; discussion 32, 35-6. PubMed ID: 8025004
[TBL] [Abstract][Full Text] [Related]
5. Combined modality therapy for non-small cell lung carcinoma.
Machtay M; Glatstein E
Cancer J; 2002; 8 Suppl 1():S55-67. PubMed ID: 12075703
[TBL] [Abstract][Full Text] [Related]
6. What is the role for surgery in patients with stage III non-small cell lung cancer?
Vandenbroucke E; De Ryck F; Surmont V; van Meerbeeck JP
Curr Opin Pulm Med; 2009 Jul; 15(4):295-302. PubMed ID: 19465855
[TBL] [Abstract][Full Text] [Related]
7. Sequencing chemotherapy, radiotherapy and surgery in combined modality treatment of stage III nonsmall cell lung cancer.
Maas KW; El Sharouni SY; Smit EF; Schramel FM
Curr Opin Pulm Med; 2007 Jul; 13(4):297-304. PubMed ID: 17534176
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients.
Kappers I; Belderbos JS; Burgers JA; van Zandwijk N; Groen HJ; Klomp HM
Lung Cancer; 2008 Mar; 59(3):385-90. PubMed ID: 17913281
[TBL] [Abstract][Full Text] [Related]
9. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
10. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
[TBL] [Abstract][Full Text] [Related]
11. Which patients with stage III non-small cell lung cancer should undergo surgical resection?
Patel V; Shrager JB
Oncologist; 2005 May; 10(5):335-44. PubMed ID: 15851792
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy in stage III non-small cell lung cancer.
Edelman MJ; Gandara DR; Roach M; Benfield JR
Ann Thorac Surg; 1996 May; 61(5):1564-72. PubMed ID: 8633990
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the management of stage IIIA non-small-cell lung cancer.
Santos ES; Castrellon A; Blaya M; Raez LE
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1913-29. PubMed ID: 19046112
[TBL] [Abstract][Full Text] [Related]
14. How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer.
Kunitoh H; Suzuki K
Br J Cancer; 2007 May; 96(10):1498-503. PubMed ID: 17473830
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies in superior sulcus tumors: a model for combined modality therapy in non-small cell lung cancer].
Girard N; Mornex F
Cancer Radiother; 2007; 11(1-2):59-66. PubMed ID: 17197220
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.
Vokes EE; Crawford J; Bogart J; Socinski MA; Clamon G; Green MR
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5045s-5050s. PubMed ID: 16000612
[TBL] [Abstract][Full Text] [Related]
17. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.
Martin LW; Correa AM; Hofstetter W; Hong WK; Komaki R; Putnam JB; Rice DC; Smythe WR; Swisher SG; Vaporciyan AA; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1601-10. PubMed ID: 16308005
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of patients with stage III non-small cell lung cancer: concurrent high-dose chemotherapy and radiotherapy].
El Sharouni SY; Aerts JG; Senan S; De Ruysscher DK; Groen HJ; Paul MA; Smit EF; Vonk EJ; Verhagen AF; Schramel FM
Ned Tijdschr Geneeskd; 2008 Dec; 152(50):2714-7. PubMed ID: 19192584
[TBL] [Abstract][Full Text] [Related]
19. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
20. Combined-modality treatment of non-small-cell lung cancer stages I-III (take home messages).
Rübe C; Fleckenstein J
Lung Cancer; 2004 Aug; 45 Suppl 2():S139-41. PubMed ID: 15552794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
